Delivery Order SPE2DE24DA010-SPE2D625F2KAA
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,495 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with an ultimate completion date of August 4, 2025. This delivery order, which contains no set-aside designation indicating full and open competition, represents a call against a larger indefinite delivery contract vehicle. The work will be performed in Santa Clara, California, and involves the...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract (No. 4569147994, titled "GALLANT") by the Department of Defense Medical Supply Chain on August 19, 2025, with a ceiling value of $38,345.80. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed in Santa Clara, California. The contract was awarded without set-aside designation, indicating full...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order for fixed-price cardiovascular medical devices with economic price adjustment, with a completion date of March 18, 2025. The award was made under an Indefinite Delivery Contract (IDC), likely an existing Blanket Purchase Agreement (BPA) between Abbott Laboratories and the Department of...
- This federal contract award, valued at $11,750.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company, through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of March 3, 2025. The award does not have a set-aside designation, indicating full and open competition. The contract provides for the delivery of...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $66,000 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as MITRCLIP and issued without set-aside provisions under full and open competition, calls for delivery to Santa Clara, California. This delivery order represents a task order against Abbott's broader federal contract...
- This is a federal contract award to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, by the Defense Logistics Agency (DLA) for the delivery of cardiovascular medical devices and related services. The contract is a Delivery Order with a fixed price and economic price adjustment, valued at $25,715.85, with a completion date of April 1, 2025. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a large,...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F2KAADelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order (Contract No. 4569302326) valued at $9,243.00 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, with an ultimate completion date of September 8, 2025. The contract utilizes fixed-price pricing with economic price adjustment and does not include a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara, California. This delivery order falls under Abbott's broader relationship with federal healthcare procurement, where the company has established itself as a critical supplier of advanced cardiovascular medical technologies to the Department of Veterans Affairs and the Defense Logistics Agency. The award reflects Abbott Vascular's strategic importance in the federal healthcare supply chain, as the company provides sophisticated cardiovascular devices and related services including stents, pacemakers, heart valves, and specialized surgical implants. Abbott Laboratories Inc. holds multiple significant indefinite delivery contracts with the DLA and VA, including a substantial $117.1 million IDC for comprehensive procedural packages covering cardiovascular technologies. This smaller delivery order represents a continuation of Abbott's role in supporting federal healthcare systems with critical medical device supply and distribution services at their Santa Clara facility.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 8/21/25 |